Increasing incidence of non-HBV- and non-HCV-related hepatocellular carcinoma: single-institution 20-year study.
Cryptogenic
HCC
NASH
NBNC-HCC
Journal
BMC gastroenterology
ISSN: 1471-230X
Titre abrégé: BMC Gastroenterol
Pays: England
ID NLM: 100968547
Informations de publication
Date de publication:
31 Jul 2021
31 Jul 2021
Historique:
received:
01
08
2020
accepted:
20
07
2021
entrez:
1
8
2021
pubmed:
2
8
2021
medline:
4
8
2021
Statut:
epublish
Résumé
We previously reported on the trends in the etiologies of hepatocellular carcinoma (HCC) diagnosed in patients between 1995 and 2009. The aims of our updated study were to evaluate the incidence, nonhepatitis B and nonhepatitis C viral (NBNC) etiologies, and clinical characteristics of HCCs occurring in patients between 1992 and 2018. The study enrolled 2171 consecutive patients with HCC between 1992 and 2018. Their medical records were reviewed. The patients were divided into two groups, patients with early diagnoses from 1992 to 2009 and those with late diagnoses from 2010 to 2018. NBNC-HCC occurred in 514 patients (23.6%). The percentage of patients with HCC who had NBNC-HCC increased from 26.5% in 2009 to 46.3% in 2018. Patients with NBNC-HCC were older (median ages from 67 to 73 years). Type 2 diabetes mellitus (48.5-60.3%: P = 0.008), hypertension (48.5-57.4%: P = 0.047), and hyperlipidemia (39.2-53.8%: P = 0.001) increased significantly in recent years. The median FIB-4 index decreased (4.37-3.61: P = 0.026) and the median platelet count increased (15.1-17.9 × 10 The prevalence of NBNC-HCC has increased rapidly even in a regional university hospital. Metabolic syndrome may be an important risk factor for HCC. HCC was also found in patients with non-cirrhotic livers. The FIB-4 index may be a useful screening method for HCC in patients with NBNC.
Sections du résumé
BACKGROUND
BACKGROUND
We previously reported on the trends in the etiologies of hepatocellular carcinoma (HCC) diagnosed in patients between 1995 and 2009. The aims of our updated study were to evaluate the incidence, nonhepatitis B and nonhepatitis C viral (NBNC) etiologies, and clinical characteristics of HCCs occurring in patients between 1992 and 2018.
METHODS
METHODS
The study enrolled 2171 consecutive patients with HCC between 1992 and 2018. Their medical records were reviewed. The patients were divided into two groups, patients with early diagnoses from 1992 to 2009 and those with late diagnoses from 2010 to 2018.
RESULTS
RESULTS
NBNC-HCC occurred in 514 patients (23.6%). The percentage of patients with HCC who had NBNC-HCC increased from 26.5% in 2009 to 46.3% in 2018. Patients with NBNC-HCC were older (median ages from 67 to 73 years). Type 2 diabetes mellitus (48.5-60.3%: P = 0.008), hypertension (48.5-57.4%: P = 0.047), and hyperlipidemia (39.2-53.8%: P = 0.001) increased significantly in recent years. The median FIB-4 index decreased (4.37-3.61: P = 0.026) and the median platelet count increased (15.1-17.9 × 10
CONCLUSIONS
CONCLUSIONS
The prevalence of NBNC-HCC has increased rapidly even in a regional university hospital. Metabolic syndrome may be an important risk factor for HCC. HCC was also found in patients with non-cirrhotic livers. The FIB-4 index may be a useful screening method for HCC in patients with NBNC.
Identifiants
pubmed: 34332532
doi: 10.1186/s12876-021-01884-5
pii: 10.1186/s12876-021-01884-5
pmc: PMC8325833
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
306Informations de copyright
© 2021. The Author(s).
Références
Hepatology. 2015 May;61(5):1547-54
pubmed: 25125077
N Engl J Med. 2011 Mar 03;364(9):829-841
pubmed: 21366474
Lancet. 2014 Aug 30;384(9945):755-65
pubmed: 25129328
Clin Gastroenterol Hepatol. 2009 Oct;7(10):1104-12
pubmed: 19523535
Am J Gastroenterol. 1999 Sep;94(9):2467-74
pubmed: 10484010
Gastroenterology. 2012 Jun;142(7):1592-609
pubmed: 22656328
Clin Gastroenterol Hepatol. 2015 May;13(5):992-9.e2
pubmed: 25459558
Hepatology. 2016 Dec;64(6):1969-1977
pubmed: 27301913
Hepatol Res. 2015 Jan;45(1):20-8
pubmed: 24661406
Hepatology. 2015 Oct;62(4):1190-200
pubmed: 26146815
J Hepatol. 2010 Jun;52(6):791-9
pubmed: 20409606
Hepatol Res. 2012 Apr;42(4):368-75
pubmed: 22151896
Clin Gastroenterol Hepatol. 2018 Aug;16(8):1356-1358
pubmed: 29199144
Hepatology. 2017 May;65(5):1557-1565
pubmed: 28130788
Clin Liver Dis. 2015 May;19(2):361-79
pubmed: 25921668
Hepatol Res. 2012 Jan;42(1):1-14
pubmed: 21917086
Hepatology. 2011 Mar;53(3):810-20
pubmed: 21319198
Gut Liver. 2020 Sep 15;14(5):537-545
pubmed: 31887811
Hepatology. 2007 Jul;46(1):32-6
pubmed: 17567829
Gastroenterology. 2004 Nov;127(5 Suppl 1):S87-96
pubmed: 15508108
J Gastroenterol. 2015 Mar;50(3):350-60
pubmed: 24929638
J Interferon Cytokine Res. 2017 Mar;37(3):97-102
pubmed: 28068153
J Gastroenterol. 2019 Jan;54(1):64-77
pubmed: 30006904
Gastroenterology. 2015 Aug;149(2):389-97.e10
pubmed: 25935633
J Clin Oncol. 2015 Feb 20;33(6):550-8
pubmed: 25512453
J Diabetes Investig. 2010 Oct 19;1(5):212-28
pubmed: 24843435
Gastroenterology. 2015 Mar;148(3):547-55
pubmed: 25461851
J Comput Assist Tomogr. 2020 Mar/Apr;44(2):168-177
pubmed: 32195795
Hepatol Res. 2020 Jan;50(1):15-46
pubmed: 31655492
J Hepatol. 2017 Aug;67(2):302-309
pubmed: 28336466
Am J Gastroenterol. 2013 Aug;108(8):1314-21
pubmed: 23752878
N Engl J Med. 2004 Oct 7;351(15):1521-31
pubmed: 15470215
J Comput Assist Tomogr. 2020 Jan/Feb;44(1):118-123
pubmed: 31939892
World J Gastroenterol. 2010 May 14;16(18):2265-71
pubmed: 20458764
Am J Gastroenterol. 2018 Feb;113(2):175-194
pubmed: 29336434
J Med Virol. 2017 Mar;89(3):476-483
pubmed: 27531586
Gut. 2010 Oct;59(10):1303-7
pubmed: 20650925
J Gastroenterol. 2016 Jun;51(6):586-96
pubmed: 26456168
J Hepatol. 2018 Oct;69(4):896-904
pubmed: 29886156
Cell. 2010 Jan 22;140(2):197-208
pubmed: 20141834
J Hepatol. 2018 Jul;69(1):182-236
pubmed: 29628281
BMC Gastroenterol. 2012 Jan 05;12:2
pubmed: 22221544
Hepatol Res. 2019 Oct;49(10):1109-1113
pubmed: 31336394
Jpn J Clin Oncol. 2012 Mar;42(3):212-21
pubmed: 22241822
J Gastroenterol Hepatol. 2013 Dec;28 Suppl 4:64-70
pubmed: 24251707
Hepatology. 2019 May;69(5):2271-2283
pubmed: 30645002
Hepatology. 2018 Jan;67(1):123-133
pubmed: 28802062
Cancer. 2009 Dec 15;115(24):5651-61
pubmed: 19834957
Gastroenterology. 2007 Jun;132(7):2557-76
pubmed: 17570226
World J Gastroenterol. 2015 Apr 14;21(14):4103-10
pubmed: 25892859
Hepatology. 2006 Apr;43(4):682-9
pubmed: 16502396
Gastroenterology. 2007 May;132(6):2169-80
pubmed: 17498510
Hepatology. 2010 May;51(5):1820-32
pubmed: 20432259
J Gastroenterol. 2019 Apr;54(4):367-376
pubmed: 30498904
CA Cancer J Clin. 2010 Jul-Aug;60(4):207-21
pubmed: 20554718